Wearable Injectors Market Analysis By Type (On-body, Off-body), Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery), By Application (Oncology, Autoimmune Disease), By End-Use, And Segment Forecasts, 2014 - 2025

Published: Sep, 2017 | Pages: 114 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global wearable injectors market is anticipated to reach USD 11.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring. The paradigm shift towards self-administration of injectable is expected to drive the market during the forecast period. In addition, increasing awareness and rising adoption of wearable injectors are expected to assist in growth.

Technological advancements in wearable injectors, such as Bluetooth integrated wearable injectors, enable sending alerts to patients, such as injection reminders, and provide patients access to data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and others prevent accidental activation. They also have audio and visual status indicators or signals. Patients can self-administer drugs subcutaneously in less time and with minimal effort as compared to intravenous or other routes. Patients are not required to visit any healthcare provider for administration.

Prevalence of lifestyle-associated diseases, such as diabetes and hypertension, is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access with minimal errors, is expected to boost the wearable injectors market.

Further key findings from the study suggest:

• The on-body segment held lucrative market share in 2016, owing to growing preference of patients for adhesive patches that release the drug easily and can be worn on the skin

• The motor-driven segment is expected to register the highest growth over the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies

• The oncology segment is expected to gain the largest market share due to increasing incidence of cancer worldwide

• North America is expected to dominate the wearable injectors market over the forecast period due to rising demand for innovative Information Technology (IT) solutions to streamline workflow and increasing regulatory requirements to ensure patient safety

• Some of the key players in wearable injectors market are Becton, Dickinson and Company; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.; Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and CeQur SA.

 Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                 1.2 Information or Data Analysis
                 1.3 Market Formulation & Validation
                 1.4 Region Wise Market Calculation
                     1.4.1 Region wise market: Base estimates
                     1.4.2 Global market: CAGR calculation

Chapter 2 Executive Summary
                 2.1 Market Snapshot

Chapter 3 Wearable Injectors Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                     3.1.1 Market driver analysis
                         3.1.1.1 Growing geriatric population & prevalence of chronic diseases
                         3.1.1.2 Rising demand for round-the-clock monitoring
                         3.1.1.3 Increasing concern over the hazards related to needlestick injuries
                         3.1.1.4 Technological developments in wearable injectors
                         3.1.1.5 Increasing need to curb healthcare costs
                     3.1.2 Market restraint analysis
                         3.1.2.1 Alternative drug delivery methods
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 Wearable Injectors - SWOT Analysis, By Factor (political & legal, economic, and technological)
                     3.3.1 Market SWOT Analysis, By Factor (political & legal, economic, and technological)
                         3.3.1.1 Political & legal factors
                             3.3.1.1.1 Strength
                             3.3.1.1.2 Weakness
                             3.3.1.1.3 Opportunity
                             3.3.1.1.4 Threat
                         3.3.1.2 Economic factors
                             3.3.1.2.1 Strength
                             3.3.1.2.2 Weakness
                             3.3.1.2.3 Opportunity
                             3.3.1.2.4 Threat
                         3.3.1.3 Technological factors
                             3.3.1.3.1 Strength
                             3.3.1.3.2 Weakness
                             3.3.1.3.3 Opportunity
                             3.3.1.3.4 Threat
                 3.4 Industry Analysis - Porter's
                     3.4.1 Porter's Five Forces analysis
                         3.4.1.1 Competitive rivalry
                         3.4.1.2 Bargaining power of suppliers
                         3.4.1.3 Bargaining power of buyers
                         3.4.1.4 Threat of new entrants
                         3.4.1.5 Threat of substitutes

Chapter 4 Wearable Injectors Type Estimates & Trend Analysis
                 4.1 Wearable Injectors Market: Type Movement Analysis
                 4.2 On-body
                     4.2.1 On-body market, 2014 - 2025 (USD Million)
                 4.3 Off-body
                     4.3.1 Off-body market, 2014 - 2025 (USD Million)

Chapter 5 Wearable Injectors Technology Estimates & Trend Analysis
                 5.1 Wearable Injectors Market: Technology Movement Analysis
                 5.2 Spring-based
                     5.2.1 Spring-based market, 2014 - 2025 (USD Million)
                 5.3 Motor-driven
                     5.3.1 Motor-driven market, 2014 - 2025 (USD Million)
                 5.4 Rotary Pump
                     5.4.1 Rotary pump market, 2014 - 2025 (USD Million)
                 5.5 Expanding Battery
                     5.5.1 Expanding battery market, 2014 - 2025 (USD Million)
                 5.6 Other
                     5.6.1 Other market, 2014 - 2025 (USD Million)

Chapter 6 Wearable Injectors Application Estimates & Trend Analysis
                 6.1 Wearable Injectors Market: Application Movement Analysis
                 6.2 Oncology
                     6.2.1 Oncology market, 2014 - 2025 (USD Million)
                 6.3 Infectious Disease
                     6.3.1 Infectious disease market, 2014 - 2025 (USD Million)
                 6.4 Cardiovascular Disease
                     6.4.1 Cardiovascular disease market, 2014 - 2025 (USD Million)
                 6.5 Autoimmune Disease
                     6.5.1 Autoimmune disease market, 2014 - 2025 (USD Million)
                 6.6 Other
                     6.6.1 Other market, 2014 - 2025 (USD Million)

Chapter 7 Wearable Injectors End-use Estimates & Trend Analysis
                 7.1 Wearable Injectors Market: End-use Movement Analysis
                 7.2 Hospital
                     7.2.1 Hospital market, 2014 - 2025 (USD Million)
                 7.3 Clinic
                     7.3.1 Clinic market, 2014 - 2025 (USD Million)
                 7.4 Home Care
                     7.4.1 Home care market, 2014 - 2025 (USD Million)
                 7.5 Other
                     7.5.1 Other market, 2014 - 2025 (USD Million)

Chapter 8 Wearable Injectors Regional Estimates & Trend Analysis, by Type, Technology, Application, and End-use
                 8.1 Wearable Injectors Market Share By Region, 2016 & 2025
                 8.2 North America
                     8.2.1 North America wearable injectors market, 2014 - 2025 (USD Million)
                     8.2.2 U.S.
                         8.2.2.1 U.S. wearable injectors market, 2014 - 2025 (USD Million)
                     8.2.3 Canada
                         8.2.3.1 Canada wearable injectors market, 2014 - 2025 (USD Million)
                 8.3 Europe
                     8.3.1 Europe wearable injectors market, 2014 - 2025 (USD Million)
                     8.3.2 UK
                         8.3.2.1 UK wearable injectors market, 2014 - 2025 (USD Million)
                     8.3.3 Germany
                         8.3.3.1 Germany wearable injectors market, 2014 - 2025 (USD Million)
                     8.3.4 France
                         8.3.4.1 France wearable injectors market, 2014 - 2025 (USD Million)
                 8.4 Asia Pacific
                     8.4.1 Asia Pacific wearable injectors market, 2014 - 2025 (USD Million)
                     8.4.2 Japan
                         8.4.2.1 Japan wearable injectors market, 2014 - 2025 (USD Million)
                     8.4.3 China
                         8.4.3.1 China wearable injectors market, 2014 - 2025 (USD Million)
                 8.5 Latin America
                     8.5.1 Latin America wearable injectors market, 2014 - 2025 (USD Million)
                     8.5.2 Brazil
                         8.5.2.1 Brazil wearable injectors market, 2014 - 2025 (USD Million)
                     8.5.3 Mexico
                         8.5.3.1 Mexico wearable injectors market, 2014 - 2025 (USD Million)
                 8.6 MEA
                     8.6.1 MEA wearable injectors market, 2014 - 2025 (USD Million)
                     8.6.2 South Africa
                         8.6.2.1 South Africa wearable injectors market, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape
                 9.1 Strategy framework
                 9.2 Company Profiles
                     9.2.1 Becton, Dickinson and Company
                         9.2.1.1 Company overview
                         9.2.1.2 Financial performance
                         9.2.1.3 Product benchmarking
                         9.2.1.4 Strategic initiatives
                     9.2.2 Johnson & Johnson Services, Inc.
                         9.2.2.1 Company overview
                         9.2.2.2 Financial performance
                         9.2.2.3 Product benchmarking
                         9.2.2.4 Strategic initiatives
                     9.2.3 F. Hoffmann-La Roche Ltd.
                         9.2.3.1 Company overview
                         9.2.3.2 Financial performance
                         9.2.3.3 Product benchmarking
                         9.2.3.4 Strategic initiatives
                     9.2.4 Unilife Corporation
                         9.2.4.1 Company overview
                         9.2.4.2 Financial performance
                         9.2.4.3 Product benchmarking
                         9.2.4.4 Strategic initiatives
                     9.2.5 SteadyMed Therapeutics, Inc.
                         9.2.5.1 Company overview
                         9.2.5.2 Financial performance
                         9.2.5.3 Product benchmarking
                         9.2.5.4 Strategic initiatives
                     9.2.6 Amgen Inc.
                         9.2.6.1 Company overview
                         9.2.6.2 Financial performance
                         9.2.6.3 Product benchmarking
                         9.2.6.4 Strategic initiatives
                     9.2.7 Insulet Corporation
                         9.2.7.1 Company overview
                         9.2.7.2 Financial performance
                         9.2.7.3 Product benchmarking
                         9.2.7.4 Strategic initiatives
                     9.2.8 Enable Injections
                         9.2.8.1 Company overview
                         9.2.8.2 Financial performance
                         9.2.8.3 Product benchmarking
                         9.2.8.4 Strategic initiatives
                     9.2.9 West Pharmaceutical Services, Inc.
                         9.2.9.1 Company overview
                         9.2.9.2 Financial performance
                         9.2.9.3 Product benchmarking
                         9.2.9.4 Strategic initiatives
                     9.2.10 CeQur SA
                         9.2.10.1 Company overview
                         9.2.10.2 Financial performance
                         9.2.10.3 Product benchmarking
                         9.2.10.4 Strategic initiatives

List of Tables

Table 1. Global cancer incidences, 2012
Table 2. Per capita health expenditure, USD, (2011 - 2014)
Table 3. List of market players
Table 4. North America wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 5. North America wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 6. North America wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 7. North America wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 8. U.S. wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 9. U.S. wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 10. U.S. wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 11. U.S. wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 12. Canada wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 13. Canada wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 14. Canada wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 15. Canada wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 16. Europe wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 17. Europe wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 18. Europe wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 19. Europe wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 20. UK wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 21. UK wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 22. UK wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 23. UK wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 24. Germany wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 25. Germany wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 26. Germany wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 27. Germany wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 28. France wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 29. France wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 30. France wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 31. France wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 32. Asia Pacific wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 33. Asia Pacific wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 34. Asia Pacific wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 35. Asia Pacific wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 36. Japan wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 37. Japan wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 38. Japan wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 39. Japan wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 40. China wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 41. China wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 42. China wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 43. China wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 44. Latin America wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 45. Latin America wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 46. Latin America wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 47. Latin America wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 48. Brazil wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 49. Brazil wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 50. Brazil wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 51. Brazil wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 52. Mexico wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 53. Mexico wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 54. Mexico wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 55. Mexico wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 56. MEA wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 57. MEA wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 58. MEA wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 59. MEA wearable injectors market, by end-use, 2014 - 2025 (USD Million)
Table 60. South Africa wearable injectors market, by type, 2014 - 2025 (USD Million)
Table 61. South Africa wearable injectors market, by technology, 2014 - 2025 (USD Million)
Table 62. South Africa wearable injectors market, by application, 2014 - 2025 (USD Million)
Table 63. South Africa wearable injectors market, by end-use, 2014 - 2025 (USD Million)